Re: SGMO's next "event"
Agree completely. The next big milestone is controlled by Pfizer and will be the starter pistol for a nice leg up. Phase 3 marks a move from the minor leagues to the majors and as you point out there are new guard rails that analysts are forced to acknowledge. SOME will have no choice but to follow those guidelines while others will follow once institutional investors begin buying. Shorts will cover even if only for a while.
We can only hope that SGMO has been so neglected that when a serious attempt to model future earning BASED ON CURRENT PIPELINE plus taking seriously the potential of current research activity that they acknowledge Sangamo will be among the winners in the genetic engineering race. It need not be THE winner, there’s room for several, but once they convince themselves that Sangamo will be viable and profitable in the next 5 years the stock will be returning to all time highs.